Phase II Study in Patients With Operable Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Pegylated Liposomal Doxorubicin (Doxil)
Sponsor: Aptium Oncology Research Network
Collaborators: Ortho Biotech Products, L.P.